HTG Molecular Diagnostics competitors

HTG Molecular Diagnostics's competitors include Precipio, 23andMe, Orig3n and Co-Diagnostics
Add company...
HTG Molecular Diagnostics
HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.
Precipio
Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine.
23andMe
23andMe is a human genome research company enabling users to study their ancestry, genealogy, and inherited traits.
Orig3n
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Co-Diagnostics
Co-Diagnostics is a molecular diagnostics company with a mathematical approach to DNA test design.
Founding Date
Founding Date
1997
Founding Date
1997
Founding Date
2006
Founding Date
2014
Founding Date
2013
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Tucson, US HQ
Locations
Omaha, US HQ
New Haven, US
Locations
Mountain View, US HQ
Locations
Boston, US HQ
Locations
Sandy, US HQ
Employees
Employees
87
Employees
19
Employees
6101% increase
Employees
4111% decrease
Employees
12
Valuation ($)
Valuation ($)
124.2 m
Valuation ($)
9.7 m
Valuation ($)
1.7 b
Valuation ($)
N/A
Valuation ($)
32.5 m
Facebook likes
Facebook likes
N/A
Facebook likes
262
Facebook likes
402.6 k
Facebook likes
6.3 k
Facebook likes
389
Twitter followers
Twitter followers
220
Twitter followers
177
Twitter followers
79.4 k
Twitter followers
14.1 k
Twitter followers
378

Financial

Revenue (est.)
Revenue (est.)
$14.8m (FY, 2017)
Revenue (est.)
$1.7m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$7.7k (FY, 2017)
Cost of goods
Cost of goods
$5m (FY, 2017)
Cost of goods
$1.4m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$302 (FY, 2017)
Gross profit
Gross profit
$9.8m (FY, 2017)
Gross profit
$292k (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
$7.4k (FY, 2017)
Net income
Net income
($19m) (FY, 2017)
Net income
($20.7m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
($7m) (FY, 2017)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 300m (2 months ago)
Latest funding round
$ 14.4m (3 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 47.2m
Total funding raised
$ 1.5m
Total funding raised
$ 829.5m
Total funding raised
$ 50m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Precipio
HQ
Omaha, US
Employees
19

Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine.

View company
23andMe
HQ
Mountain View, US
Employees
610↑ 1% increase

23andMe is a human genome research company enabling users to study their ancestry, genealogy, and inherited traits.

View company
Orig3n
HQ
Boston, US
Employees
41↓ 11% decrease

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

View company
Co-Diagnostics
HQ
Sandy, US
Employees
12

Co-Diagnostics is a molecular diagnostics company with a mathematical approach to DNA test design.

View company